Cooper Companies (NASDAQ:COO) Releases Q1 2026 Earnings Guidance

Cooper Companies (NASDAQ:COO) issued an update on its first quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.020-1.040 for the period, compared to the consensus estimate of 1.000. The company issued revenue guidance of $1.0 billion-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Cooper Companies also updated its FY 2026 guidance to 4.450-4.600 EPS.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded up $1.05 on Thursday, reaching $77.03. 5,109,095 shares of the company were exchanged, compared to its average volume of 2,409,264. The company has a 50-day moving average of $71.81 and a 200-day moving average of $71.70. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm has a market cap of $15.31 billion, a price-to-earnings ratio of 37.95, a price-to-earnings-growth ratio of 1.90 and a beta of 1.05. Cooper Companies has a 1-year low of $61.78 and a 1-year high of $104.47.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities analysts forecast that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its Board of Directors has approved a stock buyback program on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on COO shares. Barclays began coverage on Cooper Companies in a report on Monday, October 13th. They issued an “overweight” rating and a $85.00 price target on the stock. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a report on Thursday, August 28th. Morgan Stanley set a $76.00 price target on Cooper Companies and gave the company an “equal weight” rating in a research report on Thursday, August 28th. Stifel Nicolaus cut their price target on Cooper Companies from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Thursday, August 28th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $94.00 price objective on shares of Cooper Companies in a research note on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average price target of $84.77.

Insider Buying and Selling

In other Cooper Companies news, COO Gerard H. Warner III acquired 1,450 shares of the firm’s stock in a transaction dated Friday, September 5th. The shares were acquired at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the completion of the acquisition, the chief operating officer directly owned 18,319 shares of the company’s stock, valued at $1,268,224.37. This trade represents a 8.60% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of the stock in a transaction dated Monday, September 29th. The stock was acquired at an average cost of $68.39 per share, with a total value of $136,780.00. Following the transaction, the director owned 5,777 shares of the company’s stock, valued at approximately $395,089.03. This trade represents a 52.95% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders have bought 13,450 shares of company stock worth $921,064. 1.98% of the stock is owned by insiders.

Hedge Funds Weigh In On Cooper Companies

Large investors have recently added to or reduced their stakes in the business. IFP Advisors Inc lifted its position in Cooper Companies by 2,647.8% during the third quarter. IFP Advisors Inc now owns 632 shares of the medical device company’s stock valued at $43,000 after buying an additional 609 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of Cooper Companies in the 3rd quarter valued at $1,887,000. Danske Bank A S purchased a new position in shares of Cooper Companies in the 3rd quarter valued at $6,392,000. Advisory Services Network LLC acquired a new position in shares of Cooper Companies during the 3rd quarter valued at $163,000. Finally, Armistice Capital LLC purchased a new stake in Cooper Companies during the 3rd quarter worth $392,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.